03 Profile
Vital Signsby Bridgehead
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Kelley Kidwell: no licensed photograph is held, so the academic plate is shown instead.
Academic
Kelley Kidwell
Ph.D., University of Michigan biostatistician
1
0
0
0
0
0
0
0
Apr 2026MayJuneJulyAugSeptOctNovto date
1
press citation on 1 topic since 17 Apr 2026 · last quoted 17 Apr 2026
02 Quoted on · 1 of 29 topics
Kelley Kidwell: key facts
- Kind of voice
- Academic
- Role
- Ph.D., University of Michigan biostatistician
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 17 Apr 2026
04 The signal · where Kelley Kidwell sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Professor Sarah FlanaganAcademicProfessor of the University of Exeter Medical School1
- 25=David MargolinAcademicM.D., Ph.D., VP of clinical development at uniQure1
- 25=Kelley KidwellAcademicPh.D., University of Michigan biostatistician1
- 25=Susana ZaphAcademicPh.D., U.S. head of QSP at Sanofi1
- 25=Wonyul LeeAcademicPh.D., senior statistical reviewer at CDER1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Kelley Kidwell has said
By outlet · linked articles
- fiercebiotech.com1
Where Kelley Kidwell has been quoted
- 01Small pools, big ideas: How the rare disease community is reimagining clinical trialsfiercebiotech.com · 17 Apr 2026
Verbatim
“small sample, sequential, multiple assignment, randomized trial—this multi-stage trial design allows individuals to be re-randomized to other treatments based on response to their initial treatment”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.